Everafenib
Everafenib is a brain-penetrant BRAF inhibitor that potently suppresses the MAPK pathway. It demonstrates superior in vitro potency against V600E BRAF melanoma cell lines compared to dabrafenib and vemurafenib and has shown efficacy in extending survival in intracranial melanoma mouse models.
Product Specifications
Field of Research
Signal Transduction
Molecular Formula
C20H23ClFN5O2S2
Molecular Weight
484.01
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog